The role of KCNQ1 in mouse and human gastrointestinal cancers

Autor: Jeroen A.C.M. Goos, Bich L. N. Than, Gerrit A. Meijer, A Rod, David A. Largaespada, Aaron L. Sarver, Remond J.A. Fijneman, Lei Zhao, Michael G. O’Sullivan, Timothy K. Starr, Ying Zhang, Patricia M. Scott, Robert T. Cormier
Přispěvatelé: Radiology and nuclear medicine, Pathology, CCA - Oncogenesis
Rok vydání: 2014
Předmět:
Male
Cancer Research
endocrine system diseases
Tumor suppressor gene
Microarray
tumor suppressor
Colorectal cancer
Cellular detoxification
Cystic Fibrosis Transmembrane Conductance Regulator
colorectal cancer
Mucin 2
Biology
Article
Mice
03 medical and health sciences
0302 clinical medicine
Intestine
Small

Genetics
medicine
Animals
Humans
Molecular Biology
Gastrointestinal Neoplasms
Neoplasm Staging
030304 developmental biology
Mice
Knockout

Mucin-2
0303 health sciences
KCNQ1
urogenital system
Gene Expression Profiling
Cancer
Prognosis
medicine.disease
3. Good health
Gene expression profiling
Disease Models
Animal

Phenotype
medicine.anatomical_structure
030220 oncology & carcinogenesis
KCNQ1 Potassium Channel
Immunology
Paneth cell
Disease Progression
Cancer research
Female
Signal Transduction
Zdroj: Oncogene
Oncogene, 33(29), 3861-3868. Nature Publishing Group
Than, B L N, Goos, J A C M, Sarver, A L, O'Sullivan, MG, Rod, A, Starr, T K, Fijneman, R J A, Meijer, G A, Zhao, L, Zhang, Y, Largaespada, D A, Scott, P M & Cormier, R T 2014, ' The role of KCNQ1 in mouse and human gastrointestinal cancers ', Oncogene, vol. 33, no. 29, pp. 3861-3868 . https://doi.org/10.1038/onc.2013.350
ISSN: 0950-9232
DOI: 10.1038/onc.2013.350
Popis: Kcnq1, which encodes for the pore-forming α-subunit of a voltage-gated potassium channel, was identified as a gastrointestinal (GI) tract cancer susceptibility gene in multiple Sleeping Beauty DNA transposon-based forward genetic screens in mice. To confirm that Kcnq1 has a functional role in GI tract cancer, we created Apc(Min) mice that carried a targeted deletion mutation in Kcnq1. Results demonstrated that Kcnq1 is a tumor suppressor gene as Kcnq1 mutant mice developed significantly more intestinal tumors, especially in the proximal small intestine and colon, and some of these tumors progressed to become aggressive adenocarcinomas. Gross tissue abnormalities were also observed in the rectum, pancreas and stomach. Colon organoid formation was significantly increased in organoids created from Kcnq1 mutant mice compared with wild-type littermate controls, suggesting a role for Kcnq1 in the regulation of the intestinal crypt stem cell compartment. To identify gene expression changes due to loss of Kcnq1, we carried out microarray studies in the colon and proximal small intestine. We identified altered genes involved in innate immune responses, goblet and Paneth cell function, ion channels, intestinal stem cells, epidermal growth factor receptor and other growth regulatory signaling pathways. We also found genes implicated in inflammation and in cellular detoxification. Pathway analysis using Ingenuity Pathway Analysis and Gene Set Enrichment Analysis confirmed the importance of these gene clusters and further identified significant overlap with genes regulated by MUC2 and CFTR, two important regulators of intestinal homeostasis. To investigate the role of KCNQ1 in human colorectal cancer (CRC), we measured protein levels of KCNQ1 by immunohistochemistry in tissue microarrays containing samples from CRC patients with liver metastases who had undergone hepatic resection. Results showed that low expression of KCNQ1 expression was significantly associated with poor overall survival.
Databáze: OpenAIRE